The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial
Abstract
Melasma is a common disorder of cutaneous hyperpigmentation predominantly affecting the faces of women. Little is known about the aetiology of melasma, and treatment is frequently disappointing. Topical tretinoin is of benefit in treating other forms of hyperpigmentation, for example liver spots, and we therefore investigated its effectiveness in melasma. Thirty-eight women completed a randomized, vehicle-controlled study, in which they applied 0.1% tretinoin (n = 19) or vehicle cream (n = 19) once daily to the face for 40 weeks. At the end of treatment 13 (68%) of 19 tretinoin-treated patients were clinically rated as improved or much improved, compared with 1 (5%) of 19 in the vehicle group (P = 0.0006). Significant improvement first occurred after 24 weeks of tretinoin treatment. Colorimetry (an objective measure of skin colour) demonstrated a 0.9 unit lightening of tretinoin-treated melasma and a 0.3 unit darkening with vehicle (P = 0.01); these results correlated with clinical lightening (r = 0.55, P = 0.0005). Histologically, epidermal pigment was reduced 36% following tretinoin treatment, compared with a 50% increase with vehicle (P = 0.002). Reduction in epidermal pigment also correlated with clinical lightening (r = -0.41, P = 0.01). Moderate cutaneous side-effects of erythema and desquamation occurred in 88% of tretinoin-treated and 29% of vehicle-treated patients. Topical 0.1% tretinoin produces significant clinical improvement of melasma, mainly due to reduction in epidermal pigment, but improvement is slow.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Topical tretinoin for photoaged skin
Kligman, A. M., Grove, G. L., Hirose, R., & Leyden, J. J. (1986) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(86)70242-9 · Cited by 620
Cited by
Hypopigmenting agents: an updated review on biological, chemical and clinical aspects
Solano, F., Briganti, S., Picardo, M., & Ghanem, G. (2006) · Pigment Cell Research · doi:10.1111/j.1600-0749.2006.00334.x · Cited by 696
The treatment of melasma: A review of clinical trials
Gupta, A. K., Gover, M. D., Nouri, K., & Taylor, S. (2006) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.02.009 · Cited by 470
Melasma: an Up-to-Date Comprehensive Review
Ogbechie-Godec, O. A., & Elbuluk, N. (2017) · Dermatology and Therapy · doi:10.1007/s13555-017-0194-1 · Cited by 416
The melanogenesis and mechanisms of skin‐lightening agents – existing and new approaches
Gillbro, J. M., & Olsson, M. J. (2011) · International Journal of Cosmetic Science · doi:10.1111/j.1468-2494.2010.00616.x · Cited by 407
Melasma: A comprehensive update
Sheth, V. M., & Pandya, A. G. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.12.046 · Cited by 377
Metadata
- Authors
- GRIFFITHS, C. E. M., FINKEL, L. J., DITRE, C. M., HAMILTON, T. A., ELLIS, C. N., & VOORHEES, J. J.
- Venue
- British Journal of Dermatology
- Publisher
- Oxford University Press (OUP)
- Published
- 1993-10
- Volume
- 129
- Issue
- 4
- Pages
- 415-421
- ISSN
- 0007-0963 (ISSN-L)
- 1365-2133
- OpenAlex
- W2161999508
- Cited by
- 249
- References
- 1
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. https://app.cochat.ai/papers/10.1111/j.1365-2133.1993.tb03169.x
- The paper
- GRIFFITHS, C. E. M., FINKEL, L. J., DITRE, C. M., HAMILTON, T. A., ELLIS, C. N., & VOORHEES, J. J. (1993). Topical tretinoin (retinoic acid) improves melasma. A vehicle-controlled, clinical trial. British Journal of Dermatology. https://doi.org/10.1111/j.1365-2133.1993.tb03169.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.